| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comparison of Medication Alerts from Two Commercial Applications in the USA
|
Shah, Sonam N.
|
|
|
44 |
6 |
p. 661-668
|
artikel
|
| 2 |
Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi
|
Jusot, Viviane
|
|
|
44 |
6 |
p. 723
|
artikel
|
| 3 |
Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
|
Weber, Sabine
|
|
|
44 |
6 |
p. 669-680
|
artikel
|
| 4 |
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
|
Hey-Hadavi, Juliana
|
|
|
44 |
6 |
p. 619-634
|
artikel
|
| 5 |
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review
|
Bhowmick, Subhrojyoti
|
|
|
44 |
6 |
p. 635-644
|
artikel
|
| 6 |
Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis
|
Lasa, Juan S.
|
|
|
44 |
6 |
p. 645-660
|
artikel
|
| 7 |
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR
|
Bissonnette, Robert
|
|
|
44 |
6 |
p. 699-709
|
artikel
|
| 8 |
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
|
Yue, Qun-Ying
|
|
|
44 |
6 |
p. 615-617
|
artikel
|
| 9 |
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
|
Yamaoka, Kunihiro
|
|
|
44 |
6 |
p. 711-722
|
artikel
|
| 10 |
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan
|
Wakao, Rika
|
|
|
44 |
6 |
p. 681-697
|
artikel
|
Tijdschrift beschrijving